Madgwicks Lawyers recently advised UK-based infection control specialists Gama Healthcare (GAMA) on their acquisition of the Clinell division of their Australian distributor, AMCLA Pty Ltd., based in Victoria. This acquisition marks GAMA’s first entry into the Australian market.
Madgwicks’ team was led by Corporate Partner, Rick Goldberg who said:
“Although the transaction value was not large, the deal had the usual M&A issues. One complexity was that, together with GAMA’s acquisition of the target company, AMCLA Pty Ltd, it was necessary for AMCLA to contemporaneously divest its non-GAMA related business divisions to a third party. However, given the goodwill of the existing distribution relationship between GAMA and the vendor, it was pleasing to see the deal successfully concluded in a tight time frame and satisfying the needs of all parties.”
“This is a very exciting time for us, as we enhance our service in Australia”, says Dr Guy Braverman, Managing Director and Co-Founder of GAMA. “As world leaders in infection prevention we are committed to empowering healthcare professionals to make the right choices to achieve the best clinical outcomes. Through our growing team of experienced clinical nurse trainers and area managers, we can increase support and after-sales service to meet the individual needs of every hospital.”
GAMA was also advised by Grant Thornton led by Daniel Kave on tax, and Deloitte led by Austin Scott on financial due diligence.
Rick Goldberg said he looks forward to Madgwicks continuing to add value to GAMA as it embarks on its growth plan in Australia.
